---
title: "Glo-BNHL international clinical site monitoring"
ocid: "ocds-h6vhtk-042bb3"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-042bb3"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-042bb3.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-042bb3.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE UNIVERSITY OF BIRMINGHAM"
published: "2024-01-09"
---

# Glo-BNHL international clinical site monitoring

Buyer: THE UNIVERSITY OF BIRMINGHAM  
Current stage: Award  
OCID: ocds-h6vhtk-042bb3

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-042bb3)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-042bb3.json)

## Summary

The University of Birmingham has awarded a contract for the Glo-BNHL international clinical site monitoring. This procurement falls under the services category and has the main procurement method as 'limited'. The University of Birmingham is the buying organization located in Birmingham, United Kingdom. The procurement stage is 'award' with the contract signed on January 9, 2024. The tender title is 'Glo-BNHL international clinical site monitoring' in the industry category of Research and development services and related consultancy services.

This tender for the Glo-BNHL international clinical site monitoring presents business growth opportunities for vendors with expertise in clinical trials and oncology research. Specifically, businesses with experience in global monitoring, paediatric trials, and rare disease trials would be well-suited to compete. The preferred vendor, Premier Research Group Limited, was chosen based on their proven expertise in these areas, their ability to work with academic institutions and emerging sponsors, and their global reach in conducting clinical trials.

## Notice

Glo-BNHL is an international multi-arm clinical trial developed in collaboration with a number of key childhood cancer research organisations, including Innovative Therapies for Children with Cancer (ITCC) and the European Intergroup for Childhood NHL (EICNHL) in Europe, and the Children's Oncology Group (COG) in North America. The trial will be delivered globally with support from these organisations and in partnership with the C17 Council in Canada and the Australia and New Zealand Children's Haematology and Oncology Group (ANZCHOG). The trial is jointly funded by Cancer Research UK, Fight Kids Cancer and industry collaborators (currently ADC Therapeutics and Regeneron Pharmaceuticals). The funding provided is contingent upon the use of vendors with a track record of delivering clinical trials of this kind. The Cancer Research UK Clinical Trials Unit (CRCTU) at the University of Birmingham is not able to perform monitoring on an international scale, therefore a suitable third-party vendor must be engaged for this critical work.

### Lot Information

Lot 1

Glo-BNHL is an international multi-arm clinical trial developed in collaboration with a number of key childhood cancer research organisations, including Innovative Therapies for Children with Cancer (ITCC) and the European Intergroup for Childhood NHL (EICNHL) in Europe, and the Children's Oncology Group (COG) in North America. The trial will be delivered globally with support from these organisations and in partnership with the C17 Council in Canada and the Australia and New Zealand Children's Haematology and Oncology Group (ANZCHOG). The trial is jointly funded by Cancer Research UK, Fight Kids Cancer and industry collaborators (currently ADC Therapeutics and Regeneron Pharmaceuticals). The funding provided is contingent upon the use of vendors with a track record of delivering clinical trials of this kind. The Cancer Research UK Clinical Trials Unit (CRCTU) at the University of Birmingham is not able to perform monitoring on an international scale, therefore a suitable third-party vendor must be engaged for this critical work. The preferred vendor for clinical site monitoring is Premier Research. Premier were selected in 2020 to work on the Far-RMS trial after going to tender because they most closely fulfilled our needs as detailed below: They are familiar with working with academic institutions of our kind, with over 85% of their client base being emerging sponsors and academic institutes They have extensive experience in haemato-oncology projects operating globally (194 projects to date) They have experience in the paediatric arena (261 studies over the past 5 years, 17 of those global, haemato-oncology studies) They have a specialised paediatric training programme to ensure staff understand the unique challenges of paediatric research They have expertise in global monitoring, having conducted studies in 75 countries worldwide and having 21 offices worldwide

### Procurement Information

The preferred vendor for clinical site monitoring is Premier Research. They are familiar with working with academic institutions of our kind, with over 85% of their client base being emerging sponsors and academic institutes They have extensive experience in haemato-oncology projects operating globally (194 projects to date) They have experience in the paediatric arena (261 studies over the past 5 years, 17 of those global, haemato-oncology studies) They have a specialised paediatric training programme to ensure staff understand the unique challenges of paediatric research They have expertise in global monitoring, having conducted studies in 75 countries worldwide and having 21 offices worldwide When deciding upon a partner to work with us on Glo-BNHL, we felt the expertise detailed above, as well as the following other considerations, made Premier the right choice for this trial:: Proven expertise in oncology trials, particularly rare disease trials Proven expertise in paediatric trials Proven expertise in global trials Ability to perform interim and follow-up site monitoring visits (and proven experience of doing so) in the following countries: UK, Europe (Austria, Belgium, France, Germany, Italy, Netherlands, NOPHO (Sweden, Norway, Denmark, Finland), Poland, Spain), USA, Canada, Australia, New Zealand and Israel Ability to perform interim and follow-up site monitoring visits across 45 sites Ability to support the volume of data that will be produced by 30 patients per treatment arm according to the treatment schedule outlined in the Glo-BNHL protocol Ability to work with the procedures and systems of the CRCTU at the University of Birmingham Ability to develop a monitoring plan in conjunction with the Glo-BNHL trial management team

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/000664-2024 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Negotiated without publication of a contract notice |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 9 Jan 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 9 Jan 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE UNIVERSITY OF BIRMINGHAM |
| Locality | BIRMINGHAM |
| Post town | Birmingham |
| Postcode | B15 2TT |
| Country | England |
| ITL 1 | TLG West Midlands (England) |
| ITL 2 | TLG3 West Midlands |
| ITL 3 | TLG31 Birmingham |
| Local authority | Birmingham |
| Electoral ward | Edgbaston |
| Westminster constituency | Birmingham Edgbaston |
| Delivery location | TLG31 Birmingham |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | PREMIER RESEARCH GROUP |

## CPV Codes

### Divisions

- 73 - Research and development services and related consultancy services

### Codes

- 73000000 - Research and development services and related consultancy services

## Release History

- 9 Jan 2024 at 15:08 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/000664-2024

## Notice URLs

- http://www.birmingham.ac.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-042bb3. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-042bb3.json.